Share This

Public company info - CStone Pharmaceuticals , 02616.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

CStone Pharmaceuticals, 02616.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12
Net Cash Flow from Operating Activities -612,469 -1,484,024 -508,070 -1,080,722 -791,107 -240,186 -213,006
Net Cash Flow from Return on Investments & Servicing of Finance -2,136 7,450 21,543 38,915 5,111 5,754 44
　Interest Received 9,672 9,692 22,863 39,218 5,111 6,054 44
　Interest Paid -11,808 -2,242 -1,320 -303 0 -300 0
　Dividend Received 0 0 0 0 0 0 0
　Dividend Paid 0 0 0 0 0 0 0
　Others 0 0 0 0 0 0 0
Taxes (Paid) / Refunded 0 0 0 0 0 0 0
Net Cash Flow from Investing Activities 355,447 -836,244 1,157,869 -698,102 -382,812 262,246 -753,513
　Additions to Fixed Assets 0 -85,900 -31,628 -6,213 -7,012 -12,130 -1,101
　Disposal of Fixed Assets 0 0 0 0 0 0 0
　Increase in Investments 0 -190,297 0 -34,065 -286,360 -3,743,048 -767,879
　Decrease in Investments 69,391 10,125 8,482 121,795 664,666 4,017,661 15,390
　Net Cash Flow with Related Parties 0 0 0 0 -307,219 0 304,029
　Others 286,056 -570,172 1,181,015 -779,619 -446,887 -237 -303,952
Net Cash Flow before Financing Activities -259,158 -2,312,818 671,342 -1,739,909 -1,168,808 27,814 -966,475
Net Cash Flow from Financing Activities 40,275 94,546 1,390,749 2,091,635 1,662,420 0 1,010,503
　New Loans 113,042 96,215 58,582 0 0 0 0
　Loans Repayment -75,296 -18,499 -6,961 -4,683 0 0 0
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Equity Financing 2,529 16,830 1,360,928 2,096,318 1,969,639 0 706,474
　Net Cash Flow with Related Parties 0 0 0 0 -307,219 0 304,029
　Others 0 0 -21,800 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents -218,883 -2,218,272 2,062,091 351,726 493,612 27,814 44,028
Cash & Cash Equivalents at Beginning of Year 742,724 3,024,548 1,126,436 701,336 83,390 59,539 15,511
Net Cash Flow due to Change in Exchange Rate/Others 34,843 -63,552 -163,979 73,374 124,334 -3,963 0
Cash & Cash Equivalents at End of Year 558,684 742,724 3,024,548 1,126,436 701,336 83,390 59,539
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.